CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents
Pamela Becherini(Ospedale Policlinico San Martino), Michele Cea(Azienda Ospedaliera S.Maria), Alessio Nencioni(Ospedale Policlinico San Martino), Maria Eugenia Gallo Cantafio(Magna Graecia University), Fabio Guolo(Ospedale Policlinico San Martino), Roberto M. Lemoli(University of Genoa), Santina Bruzzone(University of Genoa), Katia Todoerti(Fondazione IRCCS Istituto Nazionale dei Tumori), Sara Aquino(Ospedale Policlinico San Martino), Antonino Neri(University of Milan), Elisa Gelli(Italian Institute of Technology), Antonia Cagnetta(Ospedale Policlinico San Martino), Claudia Martinuzzi(Ospedale Policlinico San Martino), Ida Perrotta(University of Calabria), Silvia Ravera(Ospedale Policlinico San Martino), Debora Soncini(University of Genoa), Giulia Giorgetti(Dana-Farber Cancer Institute), Federico Ivaldi(University of Genoa), Nicola Amodio(Magna Graecia University), Maurizio Miglino(Ospedale Policlinico San Martino), Mario Passalacqua(University of Genoa), Antonio De Flora(University of California, Los Angeles), Andrea Benzi(University of Genoa)
Cited by 12
Related Papers
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Slc12a8 is a nicotinamide mononucleotide transporter
|Nature Metabolism|2018|282